IL41409A - Lysergic acid amides and process for their preparation - Google Patents

Lysergic acid amides and process for their preparation

Info

Publication number
IL41409A
IL41409A IL41409A IL4140973A IL41409A IL 41409 A IL41409 A IL 41409A IL 41409 A IL41409 A IL 41409A IL 4140973 A IL4140973 A IL 4140973A IL 41409 A IL41409 A IL 41409A
Authority
IL
Israel
Prior art keywords
lysergic
acid
lysergic acid
preparation
active
Prior art date
Application number
IL41409A
Other languages
English (en)
Other versions
IL41409A0 (en
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HUGO001186 external-priority patent/HU164051B/hu
Priority claimed from HUGO001187 external-priority patent/HU163546B/hu
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of IL41409A0 publication Critical patent/IL41409A0/xx
Publication of IL41409A publication Critical patent/IL41409A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C07D457/08—Lysergic acid amides in which the amide nitrogen is a member of a heterocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL41409A 1972-02-04 1973-01-29 Lysergic acid amides and process for their preparation IL41409A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUGO001186 HU164051B (sv) 1972-02-04 1972-02-04
HUGO001187 HU163546B (sv) 1972-02-04 1972-02-04

Publications (2)

Publication Number Publication Date
IL41409A0 IL41409A0 (en) 1973-03-30
IL41409A true IL41409A (en) 1977-04-29

Family

ID=26318474

Family Applications (1)

Application Number Title Priority Date Filing Date
IL41409A IL41409A (en) 1972-02-04 1973-01-29 Lysergic acid amides and process for their preparation

Country Status (20)

Country Link
JP (1) JPS5221516B2 (sv)
AU (1) AU475943B2 (sv)
BE (1) BE794888A (sv)
BG (1) BG22832A3 (sv)
CA (1) CA994342A (sv)
CH (1) CH589079A5 (sv)
CS (1) CS191212B2 (sv)
DD (1) DD104299A5 (sv)
DE (1) DE2305514A1 (sv)
DK (1) DK141531B (sv)
EG (1) EG10823A (sv)
FI (1) FI54118C (sv)
FR (1) FR2190440B1 (sv)
GB (1) GB1401155A (sv)
IL (1) IL41409A (sv)
NL (1) NL178256C (sv)
NO (1) NO133670C (sv)
SE (1) SE421424B (sv)
SU (1) SU468419A3 (sv)
YU (1) YU36730B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU169073B (sv) * 1974-05-28 1976-09-28
HU168914B (sv) * 1974-07-30 1976-08-28
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
DE2802023A1 (de) * 1977-01-28 1978-08-03 Sandoz Ag Neue ergotderivate, ihre herstellung und verwendung
JPH0438472U (sv) * 1990-07-31 1992-03-31
IT1260156B (it) * 1992-08-03 1996-03-28 Fidia Spa Derivati dell'acido neuraminico
WO2012177962A1 (en) * 2011-06-23 2012-12-27 Map Pharmaceuticals, Inc. Novel fluoroergoline analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH475252A (de) * 1966-02-08 1969-07-15 Sandoz Ag Verfahren zur Herstellung neuer Lysergsäure-Derivate
AT291446B (de) * 1968-11-22 1971-07-12 Richter Gedeon Vegyeszet Verfahren zur Herstellung von neuen Apovincaminsäureamiden

Also Published As

Publication number Publication date
FR2190440A1 (sv) 1974-02-01
CA994342A (en) 1976-08-03
SE421424B (sv) 1981-12-21
FI54118C (fi) 1978-10-10
AU5163373A (en) 1974-08-01
CS191212B2 (en) 1979-06-29
YU26673A (en) 1982-02-25
DE2305514A1 (de) 1973-08-16
BE794888A (fr) 1973-05-29
JPS5221516B2 (sv) 1977-06-10
EG10823A (en) 1976-07-31
YU36730B (en) 1984-08-31
DK141531C (sv) 1980-10-06
NL7301369A (sv) 1973-08-07
BG22832A3 (sv) 1977-04-20
FI54118B (fi) 1978-06-30
JPS4886900A (sv) 1973-11-15
FR2190440B1 (sv) 1976-09-03
NO133670B (sv) 1976-03-01
IL41409A0 (en) 1973-03-30
DD104299A5 (sv) 1974-03-05
NL178256B (nl) 1985-09-16
CH589079A5 (sv) 1977-06-30
GB1401155A (en) 1975-07-16
DK141531B (da) 1980-04-14
SU468419A3 (ru) 1975-04-25
NO133670C (sv) 1976-06-09
NL178256C (nl) 1986-02-17
AU475943B2 (en) 1976-09-09

Similar Documents

Publication Publication Date Title
FI71126C (fi) Foerfarande foer framstaellning av n-(1-alkyl- eller allyl -2-pyrrolidinylmetyl)-2-metoxi-4-amino- -5-alkylsulfonylbensamider
CA1121820A (en) Quinazoline compounds
CA2583920C (en) Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
US4125620A (en) 2-[(2',6'-Disubstituted-phenyl)-imino]-imidazolidines and salts thereof
PT87988B (pt) Processo para a preparacao de diazois e de composicoes farmaceuticas que os contem
US4757069A (en) Pyridazodiazepine derivatives
KR870001087B1 (ko) 아미딘 화합물의 제조방법
IL41409A (en) Lysergic acid amides and process for their preparation
SK14672001A3 (sk) Spôsob syntézy a kryštalizácie zlúčenín obsahujúcich piperazínový kruh
IE59396B1 (en) Process for the preparation of 2-alkoxy-n-(1-azabicyclo(2.2.2)octan-3-yl)amino-benzamides
US3904633A (en) Lysergic amides
DK143804B (da) Analogifremgangsmaade til fremstilling af ergopeptinderivater
US6576764B2 (en) Synthesis and crystallization of piperazine ring-containing compounds
FI62095C (fi) Foerfarande foer framstaellning av nya 1- och d1-6-/m-(isoxazol-3-karboxiamido)fenyl)-2,3,5,6-tetrahydroimidazo(2,1-b)tiazolderivat vilka anvaends som maskmedel
CZ211196A3 (en) Process for preparing pharmaceutically acceptable salts of naphthyridonecarboxylic acid
US5110946A (en) Preparation of 4-chloro-3-sulphamoyl-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)-benzamide from 2,3-dihydro-2-methyl-1h-indole and hydroxylamine-o-sulphonic acid
US3378592A (en) Process for the production of 3, 4-dihydroxybenzyloxyaminehydrobromide
HRP980291A2 (en) Crystalline roxifiban
SU922107A1 (ru) Способ получени R,S-2,3,5,6-тетрагидро-6-фенилимидазо /2,1- @ / тиазола /тетрамизола/
US3804836A (en) N-phenyl-n'-dialkylphosphinylalkyl-piperazines
US3992409A (en) 1-Alkanesulfonyloxyalkyl-2-alkyl-3-diphenylmethylenepyrrolidines
US20040176591A1 (en) Novel synthesis and crystallization of peperazine ring-containing compounds
EP0125106B1 (en) 1-acylamino-1-cyclopentanecarboxylic acids and a process for preparing them
HU194245B (en) Process for preparing aromatic 1,4-oxazepinone and -thione derivatives
US3946042A (en) 3-Diethylamino-2,2-dimethylpropyl cinnamates